Apr 13, 2026
•
2 min read
Nw operating in 20 states and Washington, D.C., Blue Circle Health is expanding free, comprehensive support for adults living with type 1 diabetes across the country.
Apr 10, 2026
3 min read
We tested the Dexcom G7 15 Day CGM and break down wear performance, accuracy, connectivity and durability, plus we conduct a side-by-side comparison with the 10-day sensor.
Apr 6, 2026
The latest integration marks the first time an implantable continuous glucose monitor has been used to automate insulin delivery with a pump.
Mar 30, 2026
I spoke with Gary Scheiner, CDCES, about optimizing mealtime insulin, including bolus timing, carb ratios, and strategies to reduce post-meal spikes.
Mar 23, 2026
We break down the biggest tech stories from ATTD 2026 with endocrinologist Dr. David Ahn, exploring how fully closed loop systems, smarter sensing, and AI are reshaping the future of diabetes care.
Mar 20, 2026
The MiniMed Flex insulin pump launches in the U.S. this summer and features a smaller and screen-free design, smartphone control, and multiple CGM integrations.
Mar 16, 2026
A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.
Mar 9, 2026
Hanne Engan shares how a routine green card interview turned into nine days in ICE detention without proper care for her type 1 diabetes.
Feb 23, 2026
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Feb 17, 2026
We spoke with an FDA-insider about how the organization regulates diabetes tech and how recent political events have shaken up the agency.
Feb 9, 2026
Portal Diabetes is developing a fully closed-loop implantable pump that delivers insulin into the intraperitoneal cavity—achieving 4–5× faster insulin action.
Feb 2, 2026
I spoke with CDCES Gary Scheiner about how to interpret your numbers, spot trends early, and make smarter adjustments with confidence.
Jan 26, 2026
Rheos is a settings-free AID algorithm that uses health tracker wearables and AI to automate dosing for type 1 diabetes management.
Jan 19, 2026
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
Jan 9, 2026
We demo the twiist app's home screen layout, meal logging, customizable targets and alerts, Apple Watch control, and the insiights follower app.
Dec 22, 2025
We breakdown this year's biggest diabetes tech stories, including wins and fails of 2025, and what we think lies ahead in 2026.
Dec 15, 2025
How a missing feature in the CeQur Simplicity patch led one user to develop a smarter way to track doses, insulin on board, and more.
Dec 12, 2025
A step by step twiist site change breakdown that explains the full process from removing the old set to inserting the new Cleo infusion set.
Dec 5, 2025
The upgraded sensor increases wear time by 5 days and has better accuracy thanks to an enhanced algorithm.
Nov 28, 2025
4 min read
Insulet finally revealed its plans for Omnipod 6, from an upgraded algorithm to a universal pod design, and what to expect for its launch in 2027 and beyond.
Nov 26, 2025
A thoughtful deep dive into diabetes distress, the many ways it appears, and how support and tech can ease the weight.
Nov 25, 2025
A cybersecurity expert explains the precautions behind insulin pumps, CGMs, and why managing diabetes in secure government facilities requires a different level of protection.
Nov 21, 2025
We demo the Freestyle Libre 3 Plus CGM smartphone app features from the Insights tab to the settings, alerts, and daily summaries.
Nov 17, 2025
We unpack how major companies are reimagining insulin delivery through tubeless designs, smarter algorithms, and the path to a fully automated insulin system.
Nov 10, 2025
We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.
